Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Waxman

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
BMC Genomics|July 21, 2007
De-regulation of common housekeeping genes in hepatocellular carcinomaSamuel Waxman, Elisa Wurmbach
Anticancer Research|May 1, 2007
Combination of cytotoxic-differentiation therapy with 5-fluorouracil and phenylbutyrate in patients with advanced colorectal cancerMax W Sung, Samuel Waxman
Seminars in Liver Disease|February 24, 2011
Fibrolamellar carcinoma: a review with focus on genetics and comparison to other malignant primary liver tumorsStephen C Ward, Samuel Waxman
Blood|July 20, 2002
Targeted removal of PML-RARalpha protein is required prior to inhibition of histone deacetylase for overcoming all-trans retinoic acid differentiation resistance in acute promyelocytic leukemiaYongkui Jing, Lijuan Xia, Samuel Waxman
Anti-Cancer Agents in Medicinal Chemistry|May 17, 2007
Targeting the ubiquitin-proteasome pathway in cancer therapyYuki Ishii, Samuel Waxman, Doris Germain
Current Opinion in Hematology|May 27, 2009
Differentiation therapy of acute myeloid leukemia: past, present and futureKevin Petrie, Arthur Zelent, Samuel Waxman
Cancer Research|February 5, 2008
Tamoxifen stimulates the growth of cyclin D1-overexpressing breast cancer cells by promoting the activation of signal transducer and activator of transcription 3Yuki Ishii, Samuel Waxman, Doris Germain
Cancer Research|December 6, 2006
Buthionine sulfoximine enhancement of arsenic trioxide-induced apoptosis in leukemia and lymphoma cells is mediated via activation of c-Jun NH2-terminal kinase and up-regulation of death receptorsDuo Chen, Rosemarie Chan, Samuel Waxman, et al.
Oncogene|June 25, 2003
The cleavage product deltaPML-RARalpha contributes to all-trans retinoic acid-mediated differentiation in acute promyelocytic leukemia cellsYongkui Jing, Lijuan Xia, Min Lu, et al.
Oncogene|March 10, 2004
Dual effects of glutathione-S-transferase pi on As2O3 action in prostate cancer cells: enhancement of growth inhibition and inhibition of apoptosisMin Lu, Lijuan Xia, David Luo, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
BMC Genomics|July 21, 2007
De-regulation of common housekeeping genes in hepatocellular carcinomaSamuel Waxman, Elisa Wurmbach
Anticancer Research|May 1, 2007
Combination of cytotoxic-differentiation therapy with 5-fluorouracil and phenylbutyrate in patients with advanced colorectal cancerMax W Sung, Samuel Waxman
Seminars in Liver Disease|February 24, 2011
Fibrolamellar carcinoma: a review with focus on genetics and comparison to other malignant primary liver tumorsStephen C Ward, Samuel Waxman
Blood|July 20, 2002
Targeted removal of PML-RARalpha protein is required prior to inhibition of histone deacetylase for overcoming all-trans retinoic acid differentiation resistance in acute promyelocytic leukemiaYongkui Jing, Lijuan Xia, Samuel Waxman
Anti-Cancer Agents in Medicinal Chemistry|May 17, 2007
Targeting the ubiquitin-proteasome pathway in cancer therapyYuki Ishii, Samuel Waxman, Doris Germain
Current Opinion in Hematology|May 27, 2009
Differentiation therapy of acute myeloid leukemia: past, present and futureKevin Petrie, Arthur Zelent, Samuel Waxman
Cancer Research|February 5, 2008
Tamoxifen stimulates the growth of cyclin D1-overexpressing breast cancer cells by promoting the activation of signal transducer and activator of transcription 3Yuki Ishii, Samuel Waxman, Doris Germain
Cancer Research|December 6, 2006
Buthionine sulfoximine enhancement of arsenic trioxide-induced apoptosis in leukemia and lymphoma cells is mediated via activation of c-Jun NH2-terminal kinase and up-regulation of death receptorsDuo Chen, Rosemarie Chan, Samuel Waxman, et al.
Oncogene|June 25, 2003
The cleavage product deltaPML-RARalpha contributes to all-trans retinoic acid-mediated differentiation in acute promyelocytic leukemia cellsYongkui Jing, Lijuan Xia, Min Lu, et al.
Oncogene|March 10, 2004
Dual effects of glutathione-S-transferase pi on As2O3 action in prostate cancer cells: enhancement of growth inhibition and inhibition of apoptosisMin Lu, Lijuan Xia, David Luo, et al.
Pageof 8